+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Subscriptions and Recurring Payments - Global Strategic Business Report

  • PDF Icon

    Report

  • 380 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6093995
The global market for Subscriptions and Recurring Payments was valued at US$143.5 Billion in 2025 and is projected to reach US$215.0 Billion by 2032, growing at a CAGR of 6.0% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global “Subscriptions and Recurring Payments” Market - Key Trends & Drivers Summarized

Why Are Subscriptions and Recurring Payments Reshaping Consumer Commerce?

The subscriptions and recurring payments model has evolved from magazine renewals and gym memberships into a pervasive framework across digital and physical goods industries. In today’s digitally connected economy, consumers are increasingly drawn to the convenience, predictability, and personalization offered by subscription services. From streaming platforms and e-learning tools to meal kits, fitness apps, and curated subscription boxes, recurring payment systems are now embedded in daily life. The proliferation of smartphones, digital wallets, and cloud-based platforms has made it seamless for consumers to subscribe and manage their payments via a few taps. This trend reflects a shift from ownership to access, where users prioritize continual service availability over one-time purchases. Businesses are leveraging this model to ensure customer loyalty, generate predictable revenue streams, and gather real-time behavioral data that supports dynamic product development. Subscription-based pricing also democratizes access to premium products and services, allowing users to pay in manageable installments instead of making high upfront investments. The COVID-19 pandemic further accelerated adoption, with industries like fitness, education, retail, and SaaS transitioning rapidly to recurring revenue models to maintain continuity amid disruption. Today, the model underpins the global economy’s pivot toward convenience-driven, service-oriented consumer behavior.

How Is Technology Transforming the Subscriptions Ecosystem?

Technological innovation has fundamentally enhanced the architecture, efficiency, and scalability of subscription and recurring payment systems. Businesses now operate on sophisticated subscription management platforms that automate billing, handle multi-currency transactions, manage taxes, and prevent payment failures through intelligent retry logic. Payment gateways and processors have integrated advanced features such as AI-based churn prediction, real-time analytics dashboards, and dynamic pricing tools that help optimize subscriber retention and lifetime value. With the growth of cross-border e-commerce, platforms support multiple payment methods-credit/debit cards, digital wallets, bank debits, and even cryptocurrencies-to cater to diverse consumer preferences. The rise of APIs and modular fintech solutions allows businesses of all sizes to implement recurring billing seamlessly, integrating directly into CRMs, ERPs, and mobile apps. For consumers, personalized subscription management tools and apps enable them to track and adjust subscriptions easily, reducing involuntary churn and improving transparency. Enhanced authentication protocols (such as 3D Secure 2.0) and tokenization are also bolstering security and compliance with evolving regulatory frameworks like PSD2 and PCI-DSS. Furthermore, automation in dunning management (failed payment recovery) and invoice reconciliation is reducing revenue leakage and improving cash flow predictability for merchants. These advancements have made the recurring payments model not just viable, but essential, for businesses seeking long-term scalability and global reach.

Why Are Businesses Across All Sectors Embracing Subscription Revenue Models?

Businesses across virtually every vertical are rapidly adopting subscription and recurring payment models to align with the changing dynamics of customer expectations and digital service delivery. In software, SaaS platforms have replaced perpetual licenses with cloud-based monthly and annual billing cycles, enabling agile product development and feature rollouts. Media and entertainment giants like Netflix and Spotify have turned content consumption into a personalized, on-demand experience, supported by seamless auto-renewals. Retailers are using subscriptions to create loyalty and predictability, offering everything from fashion rentals and grooming products to baby supplies and pet food. In professional services, firms are transitioning to retainers or membership models that provide continuous value, improving client retention. Automotive companies are introducing car subscriptions that bundle maintenance, insurance, and access to vehicles on flexible terms-meeting the mobility-as-a-service trend. Even traditional sectors like healthcare and insurance are innovating with subscription packages for telehealth, chronic care, and micro-insurance, improving accessibility and customer satisfaction. Subscription pricing also enables deeper customer insights through usage data, enabling hyper-targeted offers, upsells, and lifecycle marketing strategies. Small and medium enterprises (SMEs), in particular, benefit from the predictability and scalability of recurring revenue, using subscription tools to level the playing field against larger competitors. This widespread adoption signals a fundamental change in how businesses deliver and monetize value in a digitally-first economy.

The Growth in the Subscriptions and Recurring Payments Market Is Driven by Several Factors

The exponential growth of the subscriptions and recurring payments market is being driven by a confluence of technological, commercial, and behavioral trends. On the technology front, advanced subscription billing software, real-time analytics, and automated compliance tools have significantly lowered the barrier for entry into recurring revenue models, enabling businesses of all sizes to adopt them at scale. In terms of end-use, the broad applicability of subscriptions across industries-from media and consumer goods to education, fitness, and professional services-has created an expansive and resilient customer base. Businesses are leveraging recurring payments to build deeper relationships, optimize cash flow, and enhance predictability in an increasingly uncertain economic environment. Consumer behavior is also evolving, with users preferring access over ownership, digital convenience over in-store transactions, and personalized services that evolve with their needs. The demand for flexibility, ongoing value, and frictionless payment experiences is driving subscription adoption globally. Additionally, the rapid expansion of digital payment infrastructure in emerging markets, combined with rising internet and smartphone penetration, is unlocking new opportunities for subscription models in regions like Asia-Pacific, Africa, and Latin America. Compliance with global regulatory standards and enhanced cybersecurity protocols is boosting consumer trust, further accelerating market adoption. Together, these drivers are shaping a global ecosystem where recurring payments are not just a feature, but a strategic imperative for business longevity and consumer satisfaction.

Report Scope

The report analyzes the Subscriptions and Recurring Payments market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Component (Services, Payment Platform); Type (Fixed Pricing Model, Variable Pricing Model); End-Use (Media & Entertainment, BFSI, Healthcare, IT & Telecom, Government & Education, Retail, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Services segment, which is expected to reach US$137.1 Billion by 2032 with a CAGR of a 4.9%. The Payment Platform segment is also set to grow at 7.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $39.1 Billion in 2025, and China, forecasted to grow at an impressive 8.9% CAGR to reach $43.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Subscriptions and Recurring Payments Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Subscriptions and Recurring Payments Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Subscriptions and Recurring Payments Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Adyen N.V., Affirm Holdings, Inc., American Express Company, Apple Inc., Braintree (a PayPal service) and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Subscriptions and Recurring Payments market report include:

  • Adyen N.V.
  • Affirm Holdings, Inc.
  • American Express Company
  • Apple Inc.
  • Braintree (a PayPal service)
  • Chargebee Inc.
  • Elavon Inc.
  • GoCardless
  • Klarna Inc.
  • Odoo S.A.
  • Paddle
  • PayPal Holdings Inc.
  • QuickBooks (Intuit Inc.)
  • Recurly Inc.
  • SlimPay SA
  • Square Inc. (Block, Inc.)
  • Stripe Inc.
  • Trustly AB
  • Zoho Corporation Pvt. Ltd.
  • Zuora Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Subunit Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Shift Toward Safer Vaccine Platforms Propels Growth of Subunit Vaccine Market
  • Rising Incidence of Emerging Infectious Diseases Expands Addressable Market Opportunity
  • Increasing Public and Private R&D Investments Drives Innovation in Vaccine Delivery
  • Global Pandemic Preparedness Initiatives Strengthen Business Case for Scalable Vaccine Technologies
  • Advancements in Recombinant DNA Technology Spurs Development of Targeted Vaccines
  • Growing Focus on Personalized Vaccines Generates Demand for Subunit Formulations
  • Regulatory Push for Faster Approval Processes Supports Market Acceleration
  • Expansion of Pediatric and Geriatric Immunization Programs Sustains Market Growth
  • Greater Awareness of Vaccine Safety Drives Adoption of Subunit Vaccines
  • Increasing Partnerships Between Biotech and Pharma Drives Product Commercialization
  • Rising Demand for Thermostable Vaccines Enhances Development Efforts
  • WHO and GAVI-led Global Immunization Campaigns Drive Market Penetration
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Subunit Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Subunit Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Subunit Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Subunit Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Protein Antigen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Protein Antigen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Protein Antigen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Polysaccharide Antigen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Polysaccharide Antigen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Polysaccharide Antigen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Diphtheria / Tetanus / Pertussis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Diphtheria / Tetanus / Pertussis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Diphtheria / Tetanus / Pertussis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for HPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for HPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for HPV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Measles / Mumps / Rubella by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Measles / Mumps / Rubella by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Measles / Mumps / Rubella by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 29: USA Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 30: USA Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: USA 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 35: Canada Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 36: Canada Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: Canada 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
JAPAN
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 41: Japan Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 42: Japan Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: Japan 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
CHINA
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 47: China Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 48: China Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 49: China 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
EUROPE
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Subunit Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Subunit Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Subunit Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 56: Europe Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 57: Europe Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 58: Europe 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
FRANCE
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 62: France Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 63: France Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 64: France 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
GERMANY
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 68: Germany Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 69: Germany Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 70: Germany 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 74: Italy Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 75: Italy Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 76: Italy 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 80: UK Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 81: UK Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 82: UK 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
SPAIN
  • Table 83: Spain Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 86: Spain Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 87: Spain Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 88: Spain 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
RUSSIA
  • Table 89: Russia Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 92: Russia Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 93: Russia Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 94: Russia 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 99: Rest of Europe Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 100: Rest of Europe 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Subunit Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Subunit Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 103: Asia-Pacific 13-Year Perspective for Subunit Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Subunit Vaccines by Product Type - Protein Antigen and Polysaccharide Antigen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 106: Asia-Pacific 13-Year Perspective for Subunit Vaccines by Product Type - Percentage Breakdown of Value Sales for Protein Antigen and Polysaccharide Antigen for the Years 2020, 2026 & 2032
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Subunit Vaccines by Disease - Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 109: Asia-Pacific 13-Year Perspective for Subunit Vaccines by Disease - Percentage Breakdown of Value Sales for Infectious Disease, Diphtheria / Tetanus / Pertussis, HPV, Measles / Mumps / Rubella and Other Diseases for the Years 2020, 2026 & 2032
AUSTRALIA
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Subunit Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adyen N.V.
  • Affirm Holdings, Inc.
  • American Express Company
  • Apple Inc.
  • Braintree (a PayPal service)
  • Chargebee Inc.
  • Elavon Inc.
  • GoCardless
  • Klarna Inc.
  • Odoo S.A.
  • Paddle
  • PayPal Holdings Inc.
  • QuickBooks (Intuit Inc.)
  • Recurly Inc.
  • SlimPay SA
  • Square Inc. (Block, Inc.)
  • Stripe Inc.
  • Trustly AB
  • Zoho Corporation Pvt. Ltd.
  • Zuora Inc.

Table Information